세계의 소림프구성 림프종 시장 보고서(2025년)

Small Lymphocytic Lymphoma Global Market Report 2025

US $ 4,490 ￦ 6,242,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,023,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,803,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

소림프구성 림프종 시장 규모는 향후 수년간 안정적인 성장세를 보일 것으로 예상되며, 2029년에는 연평균 4.45%의 연평균 복합 성장률(CAGR)로 38억 8,000만 달러에 달할 것으로 예측됩니다. 예측 기간 중 예상되는 성장의 원동력은 면역 요법에 대한 관심 증가, 표적 치료의 발전, 정밀 의학의 확대, 암 연구에 대한 투자 증가, 임상시험 증가입니다. 이 기간 중 예상되는 주요 동향으로는 표적치료와 면역치료의 혁신, 병용요법의 개발, 디지털 헬스 솔루션의 채택, 지지요법의 발전 등이 있습니다.

맞춤형 의료의 확대는 소림프구성 림프종 시장의 성장을 크게 촉진할 것으로 예측됩니다. 맞춤의료는 개인의 유전적, 환경적, 생활습관적 요인에 따라 치료 및 건강관리 결정을 조정하는 데 초점을 맞추었습니다. 유전체학, 생명공학, 데이터 분석의 발전으로 인해 보다 정확하고 효과적인 치료가 가능해지면서 발전이 가속화되고 있습니다. 소림프구성 림프종(SLL)은 표적 치료 및 맞춤 치료 전략을 지원하는 특정 유전자 돌연변이 및 바이오마커를 밝혀냄으로써 이 분야에서 매우 중요한 역할을 하고 있습니다. 예를 들어 Personalized Medicine Coalition의 보고에 따르면 2023년 FDA는 희귀질환에 대한 16건의 새로운 개인맞춤형 치료제를 승인했는데, 이는 2022년의 6건에서 크게 증가한 수치입니다. 이에 따라 개인맞춤형 의료의 발전이 소림프구성 림프종 시장의 성장을 가속할 것으로 예측됩니다.

소림프구성 림프종 시장의 주요 기업은 비공유결합형 BTK 억제제와 같은 혁신적인 치료법을 개발하여 치료 효과를 높이고, 기존 치료제에 대한 내성에 대응하며, 환자 예후를 개선하기 위해 노력하고 있습니다. 이들 억제제는 브루톤형 티로신 키나아제(BTK) 효소에 가역적으로 결합하여 작용하며, 공유결합 억제제에 따른 내성 및 부작용을 최소화하면서 B세포 악성 종양을 효과적으로 표적으로 삼고 있습니다. 예를 들어 2023년 12월 일라이 릴리는 BTK 억제제와 BCL-2 억제제를 포함한 최소 두 가지 이상의 이전 치료 경험이 있는 만성 림프구성 백혈병 또는 소림프구성 림프종 성인 환자에 대한 제이필카(성분명: 피르투르티닙)의 FDA 승인을 발표했습니다. 이번 승인은 이전 치료 경험이 많은 환자군의 중요한 니즈에 대응하는 것으로, 편의성과 강력한 치료 효과를 겸비한 경구용 치료 옵션을 제공한다는 점에서 의미가 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나바이러스의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 소 림프구성 림프종 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 용도 산업의 분석
• 세계의 소림프구성 림프종 시장 : 성장률 분석
• 세계의 소림프구성 림프종 시장 실적 : 규모와 성장, 2019-2024
• 세계의 소림프구성 림프종 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계소 림프구성 림프종 TAM(Total Addressable Market)

제6장 시장 세분화

• 세계의 소림프구성 림프종 시장 : 제품별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 캡슐
• 정제
• 주사
• 기타 제품
• 세계의 소림프구성 림프종 시장 : 투여 경로별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 경구
• 비경구
• 기타 투여 경로
• 세계의 소림프구성 림프종 시장 : 치료별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 화학요법
• 표적치료
• 줄기세포 이식
• 모노클로널 항체 요법
• 기타 치료법
• 세계의 소림프구성 림프종 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 병원 약국
• 소매 약국
• 온라인 약국
• 기타 유통 채널
• 세계의 소림프구성 림프종 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 병원
• 전문 클리닉
• 홈케어
• 기타 최종사용자
• 세계의 소림프구성 림프종 시장, 캡슐의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 경구 화학요법 캡슐
• 표적 치료 캡슐
• 면역 조절 캡슐
• 세계의 소림프구성 림프종 시장, 정제의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 경구 화학요법 정제
• 표적 치료 정제
• 면역치료 정제
• 세계의 소림프구성 림프종 시장, 주사의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 화학요법 주사
• 모노클로널 항체 주사
• 면역치료 주사
• 생물제제 주사
• 세계의 소림프구성 림프종 시장, 기타 제품의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 외용약
• 주입 요법
• SLL 바이오시밀러
• 방사성 의약품

제7장 지역별·국가별 분석

• 세계의 소림프구성 림프종 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 소림프구성 림프종 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 소림프구성 림프종 시장 : 경쟁 구도
• 소림프구성 림프종 시장 : 기업 개요
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 대기업과 혁신적 기업

• Bristol-Myers Squibb Company
• AstraZeneca PLC
• Eli Lilly and Company
• Gilead Sciences Inc.
• Amgen Inc.
• Regeneron Pharmaceuticals
• Incyte Corporation
• Exelixis Inc.
• Moffitt Cancer Center
• Kite Pharma Inc.
• Spectrum Pharmaceuticals Inc.
• Aptose Biosciences Inc.
• Secura Bio Inc.
• Infinity Pharmaceuticals Inc.
• TG Therapeutics Inc.

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

• 소림프구성 림프종 시장 2029 : 새로운 기회를 제공하는 국가
• 소림프구성 림프종 시장 2029 : 새로운 기회를 제공하는 부문
• 소림프구성 림프종 시장 2029 : 성장 전략
  • 시장 동향에 기반한 전략
  • 경쟁의 전략

제36장 부록

KSA

영문 목차

영문목차

Small lymphocytic lymphoma (SLL) is a type of cancer that affects lymphocytes, a subset of white blood cells, and typically manifests in the lymph nodes. The goal of SLL treatment is to control the proliferation of abnormal lymphocytes, manage symptoms, and enhance the patient's quality of life through therapies such as chemotherapy, immunotherapy, or targeted treatments.

The primary product types for managing SLL include capsules, tablets, injections, and others. Capsules, which are solid dosage forms enclosed in a gelatin shell, are commonly used for the oral administration of targeted therapies and chemotherapy agents to treat SLL. Treatments are delivered through various routes, including oral and parenteral methods, among others. Available treatment options include chemotherapy, targeted therapy, stem cell transplants, monoclonal antibody therapy, and other approaches. These products are distributed through hospital pharmacies, retail pharmacies, online pharmacies, and other channels. The key end users include hospitals, specialty clinics, homecare settings, and other healthcare providers.

The small lymphocytic lymphoma market research report is one of a series of new reports from The Business Research Company that provides small lymphocytic lymphoma market statistics, including the small lymphocytic lymphoma industry global market size, regional shares, competitors with the small lymphocytic lymphoma market share, detailed small lymphocytic lymphoma market segments, market trends, and opportunities, and any further data you may need to thrive in the small lymphocytic lymphoma industry. This small lymphocytic lymphoma market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The small lymphocytic lymphoma market size has grown steadily in recent years. It will grow from $3.12 billion in 2024 to $3.26 billion in 2025 at a compound annual growth rate (CAGR) of 4.71%. The growth during the historical period can be attributed to factors such as increased awareness and early detection, regulatory approvals, the expansion of clinical trials, greater understanding of small lymphocytic lymphoma (SLL), and higher participation in clinical trials.

The small lymphocytic lymphoma market size is expected to see steady growth in the next few years. It will grow to $3.88 billion in 2029 at a compound annual growth rate (CAGR) of 4.45%. The anticipated growth during the forecast period is driven by a heightened focus on immunotherapies, advancements in targeted therapies, the expansion of precision medicine, increased investment in cancer research, and a rise in clinical trials. Key trends expected in this period include innovations in targeted therapies and immunotherapies, the development of combination therapies, the adoption of digital health solutions, and progress in supportive care therapies.

The expansion of personalized medicine is anticipated to significantly boost the growth of the small lymphocytic lymphoma market. Personalized medicine focuses on tailoring treatments and healthcare decisions based on individual genetic, environmental, and lifestyle factors. Its development is fueled by advancements in genomics, biotechnology, and data analytics, enabling more precise and effective treatments. Small lymphocytic lymphoma (SLL) plays a pivotal role in this field by revealing specific genetic mutations and biomarkers that support targeted therapies and individualized treatment strategies. For example, the Personalized Medicine Coalition reported that in 2023, the FDA approved 16 new personalized treatments for rare diseases, a considerable increase from six approvals in 2022. Consequently, the progress in personalized medicine is expected to drive the growth of the small lymphocytic lymphoma market.

Leading companies in the small lymphocytic lymphoma market are creating innovative treatments, such as non-covalent BTK inhibitors, to improve therapy effectiveness, address resistance to existing treatments, and enhance patient outcomes. These inhibitors work by reversibly binding to the Bruton's tyrosine kinase (BTK) enzyme, effectively targeting B-cell malignancies while minimizing resistance and side effects associated with covalent inhibitors. For instance, in December 2023, Eli Lilly and Company announced FDA approval for Jaypirca (pirtobrutinib) for adults with chronic lymphocytic leukemia or small lymphocytic lymphoma who have undergone at least two prior lines of therapy, including a BTK inhibitor and a BCL-2 inhibitor. This approval addresses a critical need in heavily pre-treated populations and provides an oral treatment option that combines convenience with strong therapeutic action.

In February 2024, Johnson & Johnson partnered with Pharmacyclics LLC to improve the delivery of IMBRUVICA, a BTK inhibitor used in treating chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and other cancers. Pharmacyclics LLC specializes in providing services and products for SLL treatment. This collaboration aims to optimize IMBRUVICA's application, supporting better outcomes for patients with these conditions.

Major players in the small lymphocytic lymphoma market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Regeneron Pharmaceuticals, Incyte Corporation, Exelixis Inc., Moffitt Cancer Center, Kite Pharma Inc., Spectrum Pharmaceuticals Inc., Aptose Biosciences Inc., Secura Bio Inc., Infinity Pharmaceuticals Inc., TG Therapeutics Inc.

North America was the largest region in the small lymphocytic lymphoma market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in small lymphocytic lymphoma report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the small lymphocytic lymphoma market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The small lymphocytic lymphoma market consists of revenues earned by entities by providing services such as diagnostic services, medical treatments, patient management services, clinical trials, and research. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Small Lymphocytic Lymphoma Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on small lymphocytic lymphoma market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for small lymphocytic lymphoma ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The small lymphocytic lymphoma market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Capsules; Tablets; Injections; Other Products
• 2) By Route of Administration: Oral; Parenteral; Other Route of Administrations
• 3) By Treatment: Chemotherapy; Targeted Therapy; Stem Cell Transplant; Monoclonal antibody therapy; Other Treatments
• 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
• 5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End Users
• Subsegments:
• 1) By Capsules: Oral Chemotherapy Capsules; Targeted Therapy Capsules; Immunomodulatory Capsules
• 2) By Tablets: Oral Chemotherapy Tablets; Targeted Therapy Tablets; Immunotherapy Tablets
• 3) By Injections: Chemotherapy Injections; Monoclonal Antibody Injections; Immunotherapy Injections; Biologic Injections
• 4) By Other Products: Topical Medications; Infusion Therapies; Biosimilars For SLL; Radiopharmaceuticals
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; AbbVie Inc.; Bayer AG; Sanofi S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Small Lymphocytic Lymphoma Market Characteristics

3. Small Lymphocytic Lymphoma Market Trends And Strategies

4. Small Lymphocytic Lymphoma Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Small Lymphocytic Lymphoma Growth Analysis And Strategic Analysis Framework

• 5.1. Global Small Lymphocytic Lymphoma PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Small Lymphocytic Lymphoma Market Growth Rate Analysis
• 5.4. Global Small Lymphocytic Lymphoma Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Small Lymphocytic Lymphoma Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Small Lymphocytic Lymphoma Total Addressable Market (TAM)

6. Small Lymphocytic Lymphoma Market Segmentation

• 6.1. Global Small Lymphocytic Lymphoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Capsules
• Tablets
• Injections
• Other Products
• 6.2. Global Small Lymphocytic Lymphoma Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• Other Route of Administrations
• 6.3. Global Small Lymphocytic Lymphoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemotherapy
• Targeted Therapy
• Stem Cell Transplant
• Monoclonal Antibody Therapy
• Other Treatments
• 6.4. Global Small Lymphocytic Lymphoma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Other Distribution Channels
• 6.5. Global Small Lymphocytic Lymphoma Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Homecare
• Other End Users
• 6.6. Global Small Lymphocytic Lymphoma Market, Sub-Segmentation Of Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Chemotherapy Capsules
• Targeted Therapy Capsules
• Immunomodulatory Capsules
• 6.7. Global Small Lymphocytic Lymphoma Market, Sub-Segmentation Of Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Chemotherapy Tablets
• Targeted Therapy Tablets
• Immunotherapy Tablets
• 6.8. Global Small Lymphocytic Lymphoma Market, Sub-Segmentation Of Injections, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemotherapy Injections
• Monoclonal Antibody Injections
• Immunotherapy Injections
• Biologic Injections
• 6.9. Global Small Lymphocytic Lymphoma Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Medications
• Infusion Therapies
• Biosimilars For SLL
• Radiopharmaceuticals

7. Small Lymphocytic Lymphoma Market Regional And Country Analysis

• 7.1. Global Small Lymphocytic Lymphoma Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Small Lymphocytic Lymphoma Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Small Lymphocytic Lymphoma Market

• 8.1. Asia-Pacific Small Lymphocytic Lymphoma Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Small Lymphocytic Lymphoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Small Lymphocytic Lymphoma Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Small Lymphocytic Lymphoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Small Lymphocytic Lymphoma Market

• 9.1. China Small Lymphocytic Lymphoma Market Overview
• 9.2. China Small Lymphocytic Lymphoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Small Lymphocytic Lymphoma Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Small Lymphocytic Lymphoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Small Lymphocytic Lymphoma Market

• 10.1. India Small Lymphocytic Lymphoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Small Lymphocytic Lymphoma Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Small Lymphocytic Lymphoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Small Lymphocytic Lymphoma Market

• 11.1. Japan Small Lymphocytic Lymphoma Market Overview
• 11.2. Japan Small Lymphocytic Lymphoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Small Lymphocytic Lymphoma Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Small Lymphocytic Lymphoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Small Lymphocytic Lymphoma Market

• 12.1. Australia Small Lymphocytic Lymphoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Small Lymphocytic Lymphoma Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Small Lymphocytic Lymphoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Small Lymphocytic Lymphoma Market

• 13.1. Indonesia Small Lymphocytic Lymphoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Small Lymphocytic Lymphoma Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Small Lymphocytic Lymphoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Small Lymphocytic Lymphoma Market

• 14.1. South Korea Small Lymphocytic Lymphoma Market Overview
• 14.2. South Korea Small Lymphocytic Lymphoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Small Lymphocytic Lymphoma Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Small Lymphocytic Lymphoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Small Lymphocytic Lymphoma Market

• 15.1. Western Europe Small Lymphocytic Lymphoma Market Overview
• 15.2. Western Europe Small Lymphocytic Lymphoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Small Lymphocytic Lymphoma Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Small Lymphocytic Lymphoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Small Lymphocytic Lymphoma Market

• 16.1. UK Small Lymphocytic Lymphoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Small Lymphocytic Lymphoma Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Small Lymphocytic Lymphoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Small Lymphocytic Lymphoma Market

• 17.1. Germany Small Lymphocytic Lymphoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Small Lymphocytic Lymphoma Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Small Lymphocytic Lymphoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Small Lymphocytic Lymphoma Market

• 18.1. France Small Lymphocytic Lymphoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Small Lymphocytic Lymphoma Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Small Lymphocytic Lymphoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Small Lymphocytic Lymphoma Market

• 19.1. Italy Small Lymphocytic Lymphoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Small Lymphocytic Lymphoma Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Small Lymphocytic Lymphoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Small Lymphocytic Lymphoma Market

• 20.1. Spain Small Lymphocytic Lymphoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Small Lymphocytic Lymphoma Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Small Lymphocytic Lymphoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Small Lymphocytic Lymphoma Market

• 21.1. Eastern Europe Small Lymphocytic Lymphoma Market Overview
• 21.2. Eastern Europe Small Lymphocytic Lymphoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Small Lymphocytic Lymphoma Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Small Lymphocytic Lymphoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Small Lymphocytic Lymphoma Market

• 22.1. Russia Small Lymphocytic Lymphoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Small Lymphocytic Lymphoma Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Small Lymphocytic Lymphoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Small Lymphocytic Lymphoma Market

• 23.1. North America Small Lymphocytic Lymphoma Market Overview
• 23.2. North America Small Lymphocytic Lymphoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Small Lymphocytic Lymphoma Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Small Lymphocytic Lymphoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Small Lymphocytic Lymphoma Market

• 24.1. USA Small Lymphocytic Lymphoma Market Overview
• 24.2. USA Small Lymphocytic Lymphoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Small Lymphocytic Lymphoma Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Small Lymphocytic Lymphoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Small Lymphocytic Lymphoma Market

• 25.1. Canada Small Lymphocytic Lymphoma Market Overview
• 25.2. Canada Small Lymphocytic Lymphoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Small Lymphocytic Lymphoma Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Small Lymphocytic Lymphoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Small Lymphocytic Lymphoma Market

• 26.1. South America Small Lymphocytic Lymphoma Market Overview
• 26.2. South America Small Lymphocytic Lymphoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Small Lymphocytic Lymphoma Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Small Lymphocytic Lymphoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Small Lymphocytic Lymphoma Market

• 27.1. Brazil Small Lymphocytic Lymphoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Small Lymphocytic Lymphoma Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Small Lymphocytic Lymphoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Small Lymphocytic Lymphoma Market

• 28.1. Middle East Small Lymphocytic Lymphoma Market Overview
• 28.2. Middle East Small Lymphocytic Lymphoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Small Lymphocytic Lymphoma Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Small Lymphocytic Lymphoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Small Lymphocytic Lymphoma Market

• 29.1. Africa Small Lymphocytic Lymphoma Market Overview
• 29.2. Africa Small Lymphocytic Lymphoma Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Small Lymphocytic Lymphoma Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Small Lymphocytic Lymphoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Small Lymphocytic Lymphoma Market Competitive Landscape And Company Profiles

• 30.1. Small Lymphocytic Lymphoma Market Competitive Landscape
• 30.2. Small Lymphocytic Lymphoma Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Small Lymphocytic Lymphoma Market Other Major And Innovative Companies

• 31.1. Bristol-Myers Squibb Company
• 31.2. AstraZeneca PLC
• 31.3. Eli Lilly and Company
• 31.4. Gilead Sciences Inc.
• 31.5. Amgen Inc.
• 31.6. Regeneron Pharmaceuticals
• 31.7. Incyte Corporation
• 31.8. Exelixis Inc.
• 31.9. Moffitt Cancer Center
• 31.10. Kite Pharma Inc.
• 31.11. Spectrum Pharmaceuticals Inc.
• 31.12. Aptose Biosciences Inc.
• 31.13. Secura Bio Inc.
• 31.14. Infinity Pharmaceuticals Inc.
• 31.15. TG Therapeutics Inc.

32. Global Small Lymphocytic Lymphoma Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Small Lymphocytic Lymphoma Market

34. Recent Developments In The Small Lymphocytic Lymphoma Market

35. Small Lymphocytic Lymphoma Market High Potential Countries, Segments and Strategies

• 35.1 Small Lymphocytic Lymphoma Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Small Lymphocytic Lymphoma Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Small Lymphocytic Lymphoma Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료